ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-16 Cr | ₹-17 Cr | ₹-17 Cr | ₹-18 Cr | ₹-14 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ABBOTT INDIA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-16 Cr |
Mar2023 | ₹-17 Cr |
Mar2022 | ₹-17 Cr |
Mar2021 | ₹-18 Cr |
Mar2020 | ₹-14 Cr |
How is Deferred Tax Assets / Liabilities of ABBOTT INDIA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-16 Cr | Negative | |
Mar2023 | ₹-17 Cr | Negative | |
Mar2022 | ₹-17 Cr | Negative | |
Mar2021 | ₹-18 Cr | Negative | |
Mar2020 | ₹-14 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of ABBOTT INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ABBOTT INDIA | ₹66,795.7 Cr | 0.6% | 3.6% | 14.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,326.0 Cr | -2.5% | -4.7% | 11.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,562.0 Cr | -2.7% | -0.7% | 50.4% | Stock Analytics | |
CIPLA | ₹121,023.0 Cr | -1.2% | 0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,558.0 Cr | -2.3% | 8.2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,204.0 Cr | 1.4% | -1.5% | 13.3% | Stock Analytics |
ABBOTT INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ABBOTT INDIA | 0.6% |
3.6% |
14.9% |
SENSEX | -1.3% |
-0.8% |
6.3% |
You may also like the below Video Courses